Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients

Dr. Rick Greene and Dr. Basem Azab discuss the relationship of the interval between neoadjuvant chemoradiation-to-surgery in the treatment of esophageal cancer, and associated pathological complete response rate and overall survival rate. Dr. Azab is author of the Annals of Surgical Oncology article “Impact of Chemoradiation-to-Surgery Interval on Pathological Complete Response and Short- and Long-Term Overall Survival in Esophageal Cancer Patients.” Dr. Azab is a surgical oncology specialist at Sentara Healthcare, Newport News, VA.  His clinical expertise includes but is not limited to Esophageal Cancer, Endocrine Tumors, Gastrointestinal Oncology, Hepatobiliary Tumors.

Om Podcasten

"Speaking of SurgOnc" is a podcast series brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology(SSO). Dr. Frederick L. (Rick) Greene, ASO Deputy Editor, will explore and expand upon ideas and concepts described in articles published in the Annals of Surgical Oncology. Dr. Greene will interview authors and leading experts about topics of current importance in surgical oncology.